YKL-40 correlates positively with CSF sphingomyelin and galectin 3 concentrations, both molecules being key pathological biomarkers of microglial activation in AD, but surprisingly correlates negatively with brain amyloid-β deposition (82-84). This evidence concerns the gene CHI3L1 and Alzheimer disease.